117
Participants
Start Date
June 30, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
SD-809
SD-809 tablets taken twice daily for 12 weeks, includes a dose titration period and maintenance period.
Placebo
Placebo tablets taken twice daily for 12 weeks.
Tuscaloosa
Anaheim
Glendale
Oceanside
Orange
San Bernardino
San Diego
Denver
New Haven
Stamford
Washington D.C.
Boca Raton
Gainesville
Lake City
Miami
Orlando
Port Charlotte
Chicago
Baltimore
Minneapolis
Kansas City
St Louis
Albuquerque
Asheville
Durham
Raleigh
Cleveland
Philadelphia
Charleston
Memphis
Fort Worth
Salt Lake City
Prague
Gdansk
Katowice
Krakow
Lodz
Lublin
Torun
Domaša
Rožňava
Lead Sponsor
Auspex Pharmaceuticals, Inc.
INDUSTRY